Diabetic retinopathy is a leading cause of vision loss in working-age Indians. Doctor stresses that tight diabetes control, regular eye exams, and timely treatment can help protect sight from this ...

Ingelheim: Boehringer Ingelheim and Palatin Technologies, Inc., a biopharmaceutical company developing first-in-class ...

Your eyes can reveal hidden health risks like cancer, diabetes, and high blood pressure before other symptoms appear. Learn ...

Two new studies raise questions about GLP-1 weight-loss drugs and vision risks. While findings show rare links to optic nerve damage and a slight rise in diabetic retinopathy, experts urge caution, ...

For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy, according to a review published online Aug. 14 in JAMA Ophthalmology.

Novo Nordisk, the manufacturer of Ozempic, is facing a lawsuit over alleged vision problems caused by the drug ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

The agreement with Palatin follows a $1bn deal with Re-Vana earlier this year as Boehringer targets the ophthalmology market.

The NEW DAY study evaluating Iluvien for diabetic macular edema did not meet its primary endpoint, but showed favorable ...

Palatin has a research program in DR, and more specifically, in diabetic macular edema (DME), a complication of DR that ...

The researchers focused on a protein called hypoxia-inducible factor (HIF), which has been linked before to diabetic retinopathy and other eye diseases. In this new work, they discovered that during ...

British number one blind golfer Billy McAllister recalls his journey in the sport after completely losing his eyesight in ...